Skip to main content

Table 1 Comparison of selected maternal characteristics of the dydrogesterone group and the placebo group

From: Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo‐controlled trial

Characteristic

Dydrogesterone group (n = 24)

Placebo group (n = 24)

p value

Age

29.9 ± 5.7

29.2 ± 7.6

0.703

Gravidity

  

0.772

 Primigravida

13 (54.2 %)

12 (50 %)

 

 Multigravida

11 (45.8 %)

12 (50 %)

 

Parity

  

0.365

 Nulliparous

14 (58.3 %)

17 (70.8 %)

 

 Multiparous

10 (41.7 %)

7 (29.2 %)

 

History of preterm birth

2 (8.3 %)

1 (4.2 %)

1.000

BMI

22.5 ± 4.7

22.2 ± 5.9

0.83

GA at admission (weeks)

31.5 ± 2.1

31.4 ± 2.3

0.804

Median of cervical dilatation (cm)

1 (1-3)   

1 (1-3)   

0.361

  1. Data presented as mean ± SD, median (range) or n (%). BMI Body mass index, GA Gestational age